Resignation of Mr. Kiran Kumar Verma as Independent Director of the company
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals Ltd has informed BSE about changes to its Board of Directors effective July 26, 2025. Mr. Kiran Kumar Verma (DIN: 07415375) resigned as Independent Director due to other professional commitments, also stepping down from the Audit Committee and as Chairperson of the Nomination & Remuneration Committee. In his place, the Board appointed Mr. Vinod Kumar Sharma (DIN: 08502519) as Additional Non-Executive Independent Director for a 5-year term (July 26, 2025 to July 25, 2030), subject to shareholder approval. Mr. Sharma brings over 33 years of pharmaceutical industry experience, having worked with companies like Dabur, Sun Pharma, Mankind Pharma, Alkem Labs, and Unichem Labs at senior leadership levels. The Audit Committee and Nomination & Remuneration Committee have been reconstituted accordingly, with Mr. Vinod Kumar Sharma joining the Audit Committee and taking over as Chairperson of the Nomination & Remuneration Committee.
This is a routine board reshuffle with an immediate replacement already in place, preserving board composition and continuity. No significant impact expected on stock price or company operations.